SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pacific Diagnostic Technologies (PDTK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: s jones who wrote (64)1/28/1997 7:14:00 AM
From: chick in NC   of 262
 
Happy to oblidge:

The Biotrack 516 is a point-of-care testing system designed to be used by physicians to measure the levels of therapeutic drugs in patient samples. Overseas, especially in Germany, it is used for a variety of drugs, but the FDA has thusfar only cleared it for testing for valproic acid. Further approvals are expected.
Biotrack promises timely, accurate results quickly on-site -- very similar to the Stat-K. It also has an established marketing record in Europe and Japan with annual profits estimated at $1 million for 1996. If the market can be expanded into the USA, as PDTK will attempt, the need for low-cost sampling will be a major plus.

Hope this helps,

Chick in NC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News